Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative, preparation method of allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative and medicine purpose of allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative

A phenylacryloyl and diaryl technology, applied in the field of medicinal chemistry, can solve the problems of no anti-tumor activity and no obvious inhibitory effect of 5-LOX

Inactive Publication Date: 2015-12-16
CHINA PHARM UNIV
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this type of compound has no obvious inhibitory effect on 5-LOX and has no antitumor activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative, preparation method of allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative and medicine purpose of allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative
  • Allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative, preparation method of allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative and medicine purpose of allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative
  • Allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative, preparation method of allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative and medicine purpose of allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0193] Preparation of 1-(4-bromophenyl)-3-thiosemicarbazide

[0194] Suspend p-bromophenylhydrazine hydrochloride (5.0g, 0.022mol) in 20mL of absolute ethanol, add 0.5mL of concentrated hydrochloric acid, raise the temperature to 40°C, add KSCN (2.6g, 0.027mol) in batches within 40min, and complete the addition , heated up to reflux for 10h, ended the reaction, filtered while it was hot, washed the filter cake with ethanol (3 × 5mL) and discarded; after most of the solvent was evaporated from the filtrate under reduced pressure, water was added to precipitate a large amount of precipitate, left to stand, filtered with suction, The filter cake was washed with ice water to obtain 2.5 g of dark red solid, yield: 45.6%. m.p.198-200℃; ESI-MSm / z: 245.8[M-H] - .

Embodiment 2

[0196] Preparation of 4-methylsulfonylbenzoyl chloride

[0197] p-Methanesulfonylbenzoic acid (10g, 0.050mol) was suspended in 50mL of dry dichloromethane, oxalyl chloride (15mL, 0.150mol) was added, catalyzed by adding 1 drop of DMF, stirred at room temperature for 3h, the reaction was stopped, and the reaction solution was Concentrate to dryness under reduced pressure to obtain 10.1 g of white solid, yield: 92.6%, m.p.131-133°C.

Embodiment 3

[0199] Preparation of 2-(4-methylsulfonylbenzoyl)-2-(4-bromophenyl)thiosemicarbazide

[0200] Dissolve 1-(4-bromophenyl)-3-thiosemicarbazide (0.83g, 3.4mmol) in 20mL of dry acetone, drop triethylamine 5d into it, stir at room temperature, add compound 1 in batches within 30min ( 0.74g, 3.4mmol), the reaction solution gradually became turbid, after the addition, the temperature was raised to reflux for 2h, the reaction was terminated, cooled, suction filtered, the filter cake was washed with acetone (3×5mL), and dried to obtain a white solid 1.05g, the yield : 72.6%. m.p.178-180℃; ESI-MSm / z: 427.9[M-H] - .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative, a preparation method of the allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative and a medicine purpose of the allylbenzene acylation 1,5-diaryl-1,2,4-triazole derivative, and belongs to the field of medicinal chemistry. Pharmacological experiment results show that the compound has better cyclooxygenase-2 (COX-2) / 5-lipoxidase (5-LOX) inhibition activity and good anti-tumor activity, and can be used for preparing the medicine for treating tumor and other diseases or symptoms relevant to COX-2 and 5-LOX paths.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a new class of phenylacryloyl 1,5-diaryl-1,2,4-triazole derivatives and a preparation method thereof. The invention also discloses a pharmaceutical composition containing the compound and the compound is effective in treating tumors and other diseases by inhibiting the activities of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX). Use in Diseases or Conditions. Background technique [0002] In the middle of the 19th century, German pathologist Rudolf Vichow discovered leukocyte infiltration in malignant tumor tissue, and for the first time proposed that tumors may originate from chronic inflammation. Epidemiological studies have found that patients with chronic inflammation are more likely to develop secondary tumors, and up to 15% of tumor occurrence and development are related to inflammation caused by infection (CurrUrolRep, 2008, 9 (3): 243-249; RedoxRep, 2002, 7( 6):...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D249/12A61K31/4196A61P35/00
CPCY02P20/55C07D249/12
Inventor 徐进宜蔡浩徐盛涛吴晓明江波裘杨溢张朋飞沈昊姚和权谢唯佳
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com